Bridging the Gap Between Treatment and Prevention At the intersection of cancer treatment and prevention, Dr. Melissa Frey—a gynecologic oncologist, cancer geneticist, and researcher based in New York City—has long recognized the critical importance of early cancer risk assessment. Dr. Frey identified a persistent challenge: traditional …
We had the opportunity to connect with Renie and Philip Moss ahead of Neurofibromatosis Awareness Month. Philip has neurofibromatosis type 1 (NF1). It is associated with many features but most often causes growths called neurofibromas (usually benign) as well as characteristic skin and eye findings.1 Malignant or cancerous tumors are rare.1 You …